Login to Your Account



Financings Roundup

Altermune Gets Boost with $7M Seed Funding via Loxbridge JV

By Jennifer Boggs


Friday, September 23, 2011
Founded based on an unusual idea for combating multiresistant pathogens, Altermune Technologies LLC is getting a business makeover, inking a joint venture deal with Loxbridge Research LLP that brings the biotech $7 million in seed funding and allows the firm's scientists to focus on advancing the technology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription